Optimizing Pharmacokinetics in Clinical Development

Optimizing Pharmacokinetics in Clinical Development

Representing Dr. Vince Clinical Research, Dr. Toni Grant, Director of Pharmacokinetics, presented “Optimizing Pharmacokinetics in Clinical Development” at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) 2025 Annual Meeting in Washington, D.C....
Human Abuse Potential: CSS Interactions

Human Abuse Potential: CSS Interactions

Dr. Vince Clinical Research is a trusted contract research organization (CRO) for human abuse potential (HAP) trials. We understand the importance of early and consistent engagement with the FDA’s Controlled Substances Staff (CSS) to maintain regulatory compliance and...
Human Abuse Potential: Selecting a Positive Control

Human Abuse Potential: Selecting a Positive Control

As a leading contract research organization (CRO) for human abuse potential (HAP) trials, Dr. Vince Clinical Research has expertise in the creation and implementation of positive control groups. By following well-defined protocols, DVCR produces optimized results for...
Human Abuse Potential: Participant Safety

Human Abuse Potential: Participant Safety

As the leading CRO for Human Abuse Potential (HAP) studies, Dr. Vince Clinical Research has significant operational expertise in the conduct of these complex clinical trials where volunteer safety is paramount. Our clinical safety team is comprised of Advanced...
Human Abuse Potential: Pharmacy Considerations

Human Abuse Potential: Pharmacy Considerations

Dr. Vince Clinical Research operates the ideal clinical site for Human Abuse Potential (HAP) studies. One feature of this facility is the on-site cGMP Pharmacy, built to comply with DEA standards, which is required to source the majority of reference or comparator...